Clinical study of ursodeoxycholic acid in Barrett's esophagus patients

Bhaskar Banerjee, Nicholas J. Shaheen, Jessica A. Martinez, Chiu Hsieh Hsu, Eugene Trowers, Blake A. Gibson, Gary Della'Zanna, Ellen Richmond, H. H.Sherry Chow

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Prior research strongly implicates gastric acid and bile acids, two major components of the gastroesophageal refluxate, in the development of Barrett's esophagus and its pathogenesis. Ursodeoxycholic acid (UDCA), a hydrophilic bile acid, has been shown to protect esophageal cells againstoxidative stress induced bycytotoxic bile acids.Weconducted a pilot clinical study to evaluate the clinical activity of UDCA in patients with Barrett's esophagus. Twenty-nine patients with Barrett's esophagus received UDCA treatment at a daily dose of 13 to 15mg/kg/day for 6months. The clinical activity of UDCA was assessed by evaluating changes in gastric bile acid composition and markers of oxidative DNA damage (8-hydroxydeoxyguanosine), cell proliferation (Ki67), and apoptosis (cleaved caspase-3) in Barrett's esophagus epithelium. The bile acid concentrations in gastric fluidweremeasured by liquid chromatography/ mass spectrometry. At baseline, UDCA (sum of unchanged and glycine/taurine conjugates) accounted for 18.2%of total gastric bile acids. After UDCA intervention, UDCA increased significantly to account for 93.4% of total gastric bile acids (P < 0.0001). The expression of markers of oxidative DNA damage, cell proliferation, and apoptosis was assessed in the Barrett's esophagus biopsies by IHC. The selected tissue biomarkers were unchanged after 6 months of UDCA intervention. We conclude that high-dose UDCA supplementation for 6 months resulted in favorable changes in gastric bile acid composition but did not modulate selected markers of oxidative DNA damage, cell proliferation, and apoptosis in the Barrett's esophagus epithelium.

Original languageEnglish (US)
Pages (from-to)528-533
Number of pages6
JournalCancer Prevention Research
Volume9
Issue number7
DOIs
StatePublished - Jul 2016

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Clinical study of ursodeoxycholic acid in Barrett's esophagus patients'. Together they form a unique fingerprint.

  • Cite this